Sign Out
Mefenamic Acid may prolong prothrombin time. Therefore, when the drug is administered to patients receiving oral anticoagulant drugs, frequent monitoring of prothrombin time is necessary.
Mefenamic Acid may reduce the excretion of lithium, leading to significant increase in the steady-state plasma lithium levels. Hence, increased plasma lithium level monitoring is recommended.
